Randy Hicks, MD, and Carrie Berlin discuss how Regional Medical Imaging successfully met the criteria for the federal government’s meaningful use program, becoming an early adopter among radiology practices.
[[{"type":"media","view_mode":"media_crop","fid":"11557","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_4842072948677","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"210","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]Regional Medical Imaging, based in Flint, Mich., has successfully met the criteria for the federal government’s meaningful use program, becoming an early adopter among radiology practices. The group also received $216,000 in incentive funds so far for their efforts.
Here, Randy Hicks, MD, CEO of Regional Medical Imaging, and Carrie Berlin, chief information officer for RMI, discuss why meaningful use is important, how they implemented and attested to their use of the Merge RIS 7.0, and what other practices should consider when working toward meaningful use.
Can a CT-Based Radiomics Model Bolster Detection of Malignant Thyroid Nodules?
May 3rd 2024A computed tomography (CT)-based radiomics model that includes 28 radiomic features showed significantly higher accuracy, sensitivity, and specificity than conventional CT in differentiating benign and malignant thyroid nodules, according to newly published research.
Contrast-Enhanced Mammography and Dense Breasts: What a New Meta-Analysis Reveals
May 1st 2024The 10-study meta-analysis demonstrated that contrast-enhanced mammography has a 95 percent sensitivity rate and an 81 percent specificity rate for diagnosing suspicious lesions in women with dense breasts.